| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Immunology |
Centre National de la Recherche Scientifique, Laboratoire dimmunologie des tumeurs, Faculté des sciences pharmaceutiques et biologiques de Paris, Université René Descartes Paris 5, 75006 Paris [V. D-M., S. R., D. B.]; Institut National de la Santé et de la Recherche Médicale, Cytokines et Immunologie des Tumeurs Humaines [M. E. B., H. E., G. D., J. T., I. V., J. M., S. C., F. M-C.], Département de Biologie Oncologique [D. B.], Institut Gustave Roussy, 94805 Villejuif; and Service dAnatomie-Pathologie, Institut Mutualiste Montsouris [P. V.] and Laboratoire de Biochimie des Signaux Régulateurs Cellulaires et Moléculaires, Centre National de la Recherche Scientifique-Universite Pierre et Marie Curie [M. L.], 75014 Paris, France
We described previously a CTL clone able to lyse the autologous carcinoma cell line IGR-Heu after specific recognition of an HLA-A2/mutated
-actinin-4 peptide complex. Here, we used IGR-Heu, cultured either as standard two-dimensional monolayers or as three-dimensional spheroids, to further analyze the influence of target architecture on CTL reactivity. Interestingly, we found that changes in the tumor structure from two- to three-dimensional induced a dramatic decrease in its capacity to activate autologous CTL, as measured by IFN-
and tumor necrosis factor-
secretion. These functional alterations were attributable neither to MHC class I expression nor to tumor antigen (Ag) down-regulation, because IGR-Heu, cultured as two- or three-dimensional, expressed similar levels of HLA-A2 and
-actinin-4. More importantly, incubation of three-dimensional cells with synthetic epitope completely restored cytokine release by CTL. This defective Ag presentation correlated with a decrease in heat shock protein (hsp)70 expression by three-dimensional tumors compared with two-dimensional cells. Furthermore, transfection of the tumor cells with hsp70 cDNA completely restored the Ag-presenting potential of spheroids and, therefore, cytokine production by T cells. These data strongly suggest that hsp70 down-regulation in three-dimensional cells may result in tumor resistance to the immune response.
This article has been cited by other articles:
![]() |
L. Hambach, M. Vermeij, A. Buser, Z. Aghai, T. van der Kwast, and E. Goulmy Targeting a single mismatched minor histocompatibility antigen with tumor-restricted expression eradicates human solid tumors Blood, September 1, 2008; 112(5): 1844 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, X. He, Z. Wang, D. Wu, H. Zhang, C. Xu, H. He, L. Cui, D. Ba, and W. He Identification of Human T Cell Receptor {gamma}{delta}-recognized Epitopes/Proteins via CDR3{delta} Peptide-based Immunobiochemical Strategy J. Biol. Chem., May 2, 2008; 283(18): 12528 - 12537. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. O. Dowling and D. Bienzle Gene-expression changes induced by Feline immunodeficiency virus infection differ in epithelial cells and lymphocytes J. Gen. Virol., August 1, 2005; 86(8): 2239 - 2248. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jalili, M. Makowski, T. Switaj, D. Nowis, G. M. Wilczynski, E. Wilczek, M. Chorazy-Massalska, A. Radzikowska, W. Maslinski, L. Bialy, et al. Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic Cells Clin. Cancer Res., July 1, 2004; 10(13): 4498 - 4508. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |